07:53 AM EDT, 10/06/2025 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) said Monday it appointed Bilal Arif as chief operating officer and Linea Aspesi as chief people officer, effective the same day.

Arif steps into the role left vacant by Jebediah Ledell, who resigned on May 12.

Arif most recently served as chief technical operations officer of Sarepta Therapeutics, KalVista said.

Aspesi most recently served as chief administration officer and chief people officer of Editas Medicine, according to a statement.